Loading clinical trials...
Loading clinical trials...
Pregnancy Outcomes in Multiple Sclerosis Populations Exposed and Unexposed to Interferon β - a Register-based Study in the Nordic Countries
Conditions
Interventions
Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
Extavia (interferon beta-1b), Novartis Pharma AG
+5 more
Locations
1
Finland
Many locations
Multiple Locations, Finland
Start Date
May 2, 2016
Primary Completion Date
August 14, 2018
Completion Date
August 14, 2018
Last Updated
August 14, 2019
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
Bayer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions